HyperRAB

DRUG2 trials

Sponsors

Bio Products Laboratory, Washington University School of Medicine

Conditions

HealthyHealthy Participants

Early Phase 1

Washington University WU 409: Immune Responses to Rabies Vaccine.

CompletedNCT07399951

Washington University School of MedicineHealthy Participants

Start: 2023-07-18End: 2025-10-01Updated: 2026-02-10

Phase 2

Safety and Effectiveness of BPL HRIG With Active Rabies Vaccine in Healthy Subjects

CompletedNCT03264157

Bio Products LaboratoryHealthy

Start: 2017-12-08End: 2018-07-13Updated: 2020-02-25